Nu Skin Enterprises, Inc. (NUS) financial statements and ratios from SEC XBRL: revenue $1.49B (TTM), net margin 10.8%, revenue growth -17.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $1.49B |
| Net Margin | 10.8% |
| Revenue Growth (YoY) | -17.1% |
| EPS Growth (YoY) | -1295.3% |
| FCF Growth (YoY) | -86.1% |
| EV / EBITDA | 6.4 |
| Price / Book | 0.43 |
| Price / Sales | 0.17 |
| FCF Yield | 4.7% |
| DCF Value (model) | $12.36 |
| DCF Upside vs Price | 160.8% |
| Altman Z-Score | 3.54 (safe) |
| Piotroski F-Score | 7/9 |
| Sector P/E (Consumer Discretionary) | 20.7 |
NUS overview · NUS earnings · NUS KPIs · NUS investor relations · NUS ownership · NUS peers · NUS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.